Psychiatric sequelae following breast cancer chemotherapy: A pilot study using claims data

Psychosomatics

Volumn 46, Issue 6, 2005, Pages 517-522

  Miller, Shannon L B ^b   Jones, Laura E ^b   Carney, Caroline P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUSTMENT DISORDER; ADULT; AGED; ANXIETY DISORDER; ARTICLE; AWARENESS; BREAST CANCER; CANCER CHEMOTHERAPY; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; PILOT STUDY; PREVALENCE; RISK FACTOR; SLEEP DISORDER; UNITED STATES;

EID: 27644469239     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.46.6.517     Document Type: Article

References (36)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ: Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8-29
2. Harlan LC, Abrams J, Warren JL, Clegg L, Stevens J, Ballard-Barbash R: Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncology 2002; 20:1809-1817
3. Department of Health and Human Services www.hhs.gov/news/ press/2003pres/20031003bl (accessed 10/22/04)
4. Du X, Goodwin JS: Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J Clin Oncol 2001; 19:1455-1461
5. Chen H, Cantor A, Meyer J, Beth Corcoran M, Grendys E, Cavanaugh D, Antonek S, Camarata H, Haley W, Balducci L, Extermann M: Can older patients tolerate chemotherapy? A prospective pilot study. Cancer 2003; 97:1107-1114
6. Balducci L, Lyman GH: Patients aged > or = 70 are at high risk for neutropenic infections and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy. J Clin Oncol 2000; 19:1583-1585
7. Kimmick GG, Fleming R, Muss HB, Balducci L: Cancer chemotherapy in older adults: a tolerability perspective. Drugs Aging 1997; 10:34-49
8. Cathcart CK, Jones SE, Pumroy CS, Peters GN, Know SM, Cheek JH: Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 1993; 27:277-281
9. Fulton CL: The physical and psychological symptoms experienced by patients with metastatic breast cancer before death. Eur J Cancer Care 1997; 6:262-266
10. Maguire GP, Lee EG, Bevingon DJ, Kuchemann CS, Crabtree RJ, Cornell CE: Psychiatric problems in the first year after mastectomy. BMJ 1978; 1:963-965
11. Pinder KL, Ramirez AJ, Black MA, Richards MA, Gregory WM, Rubens RD: Psychiatric disorders in patients with advanced breast cancer: prevalence and associated factors. Eur J Cancer 1993; 29A:524-527
12. Ramirez AJ, Richards MA, Jarrett SR, Fentiman IS: Can mood disorder in women with breast cancer be identified preoperatively? Br J Cancer 1995; 72:1509-1512
13. Mermelstein HT, Lesko L: Depression in patients with cancer. Psycho-Oncology 1992; 1:199-215
14. Fulton C: The prevalence and detection of psychiatric morbidity in patients with metastatic breast cancer. Eur J Cancer Care 1998; 7:232-239
15. Hall A, A'Hern R, Fallowfield L: Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer 1999; 35:79-85
16. Schagen SB, Muller MJ, Boogerd W, Rosenbrand RM, van Rhijn D, Rodenhuis S, van Dam FS: Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 2002; 13:1387-1397
17. Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM: Neuropsychological impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002; 20:485-493
18. Brezden CB, Phillips K-A, Abdolell M, Bunston T, Tannock IF: Cognititive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000; 18:2695-2701
19. Wieneke MH, Dienst ER: Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 1995; 4:61-66
20. van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Fortuyn ME, Rodenhuis S: Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Nat Cancer Inst 1998; 90:210-218
21. Du XL, Osborne C, Goodwin JS: Population-based assessment of hospitalization for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 2002; 20:4636-4642
22. Woods CR: Impact of different definitions on estimates of accuracy of the diagnosis data in a clinical database. J Clin Epidemiol 2001; 54:782-788
23. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, APA, 1994
24. Derogatis LR, Morrow GR, Felting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL Jr: The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249: 751-757
25. Lurie N, Popkin M, Dysken M: Accuracy of diagnoses of schizophrenia in Medicaid claims. Hosp Comm Psychiatry 1992; 43: 69-71
26. Woolcott DL, Wellish DK, Fawzy FI, Landsverk J: Adaptation of adult bone marrow transplant receipient long-term survivors. Transplantation 1986; 41:478-484
27. Bush NE, Haberman M, Donaldson G, Sullivan KM: Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Soc Sci Med 1995; 40:479-490
28. Morris T, Greer HS, White P: Psychological and social adjustment to mastectomy: a two-year follow-up study. Cancer 1977; 40: 2381-2387
29. Kornblith AB: Psychosocial adaptation of cancer survivors, in Psycho-Oncology. Edited by Holland JC. New York, Oxford University Press, 1998, p 234
30. Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, Fisher E, Womark N, Deutsch M, Montague E, Saffer E, Wicherham DL, Lerner H, Glass A, Shibata H, Deckers P, Ketcham A, Oishi R, Russel I: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985; 312:665-673
31. NIH Consensus Conference - Early stage breast cancer. JAMA 1991; 265:391-395
32. Du X, Freeman JL, Goodwin JS: Information on radiation treatment in patients with breast cancer: the advantages of the linked Medicare and SEER data. J Clin Epidemiol 1999; 52:463-470
33. Lazovich DA, White E, Thomas DB, Moe RE: Underutilization of breast-conserving surgery and radiation therapy among women with state I or II breast cancer. JAMA 1991; 266:3422-3438
34. Patton ML, Moss BE, Kraut JD, Germain TJ, Haith LR Jr, Shotwell BA, Reilly KJ: Underutilization of breast-conservation surgery with radiation therapy for women with stage Tis, I or II breast cancer. Int Surg 1996; 81:423-427
35. Farrow DC, Hunt WC, Samet JM: Geographical variation in the treatment of localized breast cancer. N Engl J Med 1992; 326: 1097-1101
36. Demlo LK, Campbell PM, Brown SS: Reliability of information abstracted from patient's medical records. Med Care 1978; 16: 995-1005